company background image
EKAD

Ekadharma InternationalIDX:EKAD Stock Report

Market Cap

Rp1.0t

7D

1.1%

1Y

13.4%

Updated

20 Oct, 2021

Data

Company Financials
EKAD fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends4/6

EKAD Overview

PT Ekadharma International Tbk, together with its subsidiaries, manufactures and markets self-adhesive tapes in Indonesia and Malaysia.

Price History & Performance

Summary of all time highs, changes and price drops for Ekadharma International
Historical stock prices
Current Share PriceRp1,435.00
52 Week HighRp1,135.00
52 Week LowRp1,795.00
Beta0.47
1 Month Change2.50%
3 Month Change1.77%
1 Year Change13.44%
3 Year Change88.82%
5 Year Change119.08%
Change since IPO955.15%

Recent News & Updates

Shareholder Returns

EKADID Commercial ServicesID Market
7D1.1%-0.4%2.6%
1Y13.4%13.0%27.7%

Return vs Industry: EKAD matched the ID Commercial Services industry which returned 13% over the past year.

Return vs Market: EKAD underperformed the ID Market which returned 27.7% over the past year.

Price Volatility

Is EKAD's price volatile compared to industry and market?
EKAD volatility
EKAD Beta0.47
Industry Beta0.48
Market Beta1

Stable Share Price: EKAD is less volatile than 75% of ID stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: EKAD's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1981590Judi Leonardihttps://www.ekadharma.com

PT Ekadharma International Tbk, together with its subsidiaries, manufactures and markets self-adhesive tapes in Indonesia and Malaysia. The company offers aluminum foil, anti-slip, cloth, double foam, double side, Kraft, masking, metalizing, OPP, OPP printing, PVC electrical insulation, and stationery tapes; stretch films; epoxy, water, and white glues; and glue sticks under the DAIMARU, SUPERFIX, and EKATAPE brands. It also provides carton sealers and stretch wrappers.

Ekadharma International Fundamentals Summary

How do Ekadharma International's earnings and revenue compare to its market cap?
EKAD fundamental statistics
Market CapRp1.00t
Earnings (TTM)Rp100.64b
Revenue (TTM)Rp630.92b

10.0x

P/E Ratio

1.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
EKAD income statement (TTM)
RevenueRp630.92b
Cost of RevenueRp400.41b
Gross ProfitRp230.51b
ExpensesRp129.87b
EarningsRp100.64b

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)144.02
Gross Margin36.54%
Net Profit Margin15.95%
Debt/Equity Ratio2.8%

How did EKAD perform over the long term?

See historical performance and comparison

Dividends

2.4%

Current Dividend Yield

24%

Payout Ratio

Valuation

Is Ekadharma International undervalued compared to its fair value and its price relative to the market?

9.7%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: EKAD (IDR1435) is trading below our estimate of fair value (IDR1588.44)

Significantly Below Fair Value: EKAD is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: EKAD is good value based on its PE Ratio (10x) compared to the ID Commercial Services industry average (20.2x).

PE vs Market: EKAD is good value based on its PE Ratio (10x) compared to the ID market (21.3x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate EKAD's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: EKAD's PB Ratio (1x) is in line with the ID Commercial Services industry average.


Future Growth

How is Ekadharma International forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

16.0%

Forecasted Commercial Services industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ekadharma International has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Ekadharma International performed over the past 5 years?

1.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: EKAD has high quality earnings.

Growing Profit Margin: EKAD's current net profit margins (16%) are higher than last year (11.3%).


Past Earnings Growth Analysis

Earnings Trend: EKAD's earnings have grown by 1.6% per year over the past 5 years.

Accelerating Growth: EKAD's earnings growth over the past year (22.6%) exceeds its 5-year average (1.6% per year).

Earnings vs Industry: EKAD earnings growth over the past year (22.6%) exceeded the Commercial Services industry -70.1%.


Return on Equity

High ROE: EKAD's Return on Equity (10.4%) is considered low.


Financial Health

How is Ekadharma International's financial position?


Financial Position Analysis

Short Term Liabilities: EKAD's short term assets (IDR626.2B) exceed its short term liabilities (IDR78.3B).

Long Term Liabilities: EKAD's short term assets (IDR626.2B) exceed its long term liabilities (IDR59.7B).


Debt to Equity History and Analysis

Debt Level: EKAD's debt to equity ratio (2.8%) is considered satisfactory.

Reducing Debt: EKAD's debt to equity ratio has reduced from 8.1% to 2.8% over the past 5 years.

Debt Coverage: EKAD's debt is well covered by operating cash flow (520.8%).

Interest Coverage: EKAD earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Ekadharma International current dividend yield, its reliability and sustainability?

2.44%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: EKAD's dividend (2.44%) is higher than the bottom 25% of dividend payers in the ID market (0.99%).

High Dividend: EKAD's dividend (2.44%) is low compared to the top 25% of dividend payers in the ID market (3.77%).


Stability and Growth of Payments

Stable Dividend: EKAD's dividends per share have been stable in the past 10 years.

Growing Dividend: EKAD's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (24.3%), EKAD's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

24.3yrs

Average board tenure


CEO

Judi Leonardi (71 yo)

40.75yrs

Tenure

Ms. Judi Widjaja Leonardi serves as the President Director at PT Ekadharma International Tbk (formerly known as PT Ekadharma Tape Industries Tbk).


Board Members

Experienced Board: EKAD's board of directors are seasoned and experienced ( 24.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

PT Ekadharma International Tbk's employee growth, exchange listings and data sources


Key Information

  • Name: PT Ekadharma International Tbk
  • Ticker: EKAD
  • Exchange: IDX
  • Founded: 1981
  • Industry: Office Services and Supplies
  • Sector: Commercial Services
  • Market Cap: Rp1.003t
  • Shares outstanding: 698.78m
  • Website: https://www.ekadharma.com

Number of Employees


Location

  • PT Ekadharma International Tbk
  • Kawasan Industri Pasar Kemis Blok C-1
  • Jl. Raya Pasar Kemis
  • Tangerang
  • Banten
  • 15560
  • Indonesia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/20 10:09
End of Day Share Price2021/10/19 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.